Clinical Trials Logo

General Population clinical trials

View clinical trials related to General Population.

Filter by:

NCT ID: NCT06294080 Not yet recruiting - General Population Clinical Trials

Effects of Dance and Tai Chi on Balance and Wellbeing on Healthy Adults

Start date: September 2024
Phase: N/A
Study type: Interventional

The aim of the proposed randomised controlled study is to compare the effects and efficacy between a dance, a Tai Chi and a waiting list control group intervention over an eight-week period on physical functions and mental benefits among non-clinical adults aged between 18 and 59. The study's primary outcome is mental wellbeing and secondary parameters are physical functional and mood. A tertiary outcome will examine how the physical and mental parameters change during the learning and practice phases

NCT ID: NCT06166810 Recruiting - General Population Clinical Trials

Capture of Healthy Gut Bacteria Associated to High Fiber Diet

iTARGET
Start date: October 24, 2023
Phase:
Study type: Observational [Patient Registry]

The role of the intestinal microbiota on health is now well recognised, and diet is one of the factors influencing the maintenance of a healthy intestinal microbiota. More specifically, the consumption of fruit, vegetables and cereals is associated with good health and, in particular, with an increase in the relative abundance of bacterial groups described as beneficial. To date, a large number of bacterial species in the intestinal microbiota have yet to be isolated and cultivated, which limits the characterisation of their potential health benefits. In order to isolate and cultivate these intestinal bacteria, it is particularly relevant to recruit individuals with a high-fibre diet.

NCT ID: NCT06017687 Recruiting - General Population Clinical Trials

Data Collection and Evaluation of OptiBP Under Investigational Use

Start date: September 28, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to collect data to develop and evaluate the use of state-of-the-art machine learning approaches within a mobile phone application for the estimation of blood pressure.

NCT ID: NCT05758961 Recruiting - General Population Clinical Trials

The French Gut: Characterization of Gut Microbiota Profiles in France

Start date: September 15, 2022
Phase:
Study type: Observational

" The French Gut " is a national contribution aiming to collect 100,000 faecal samples and associated nutritional and clinical data by 2027. Le French Gut is initiated by MetaGenoPolis-INRAE, supported by INRAE with Prof. R. Benamouzig, (AP-HP) as principal investigator of the project. The main goal of this national trial is a better understanding of the observed heterogeneity between gut microbiome of healthy subjects, its connections with the diet and lifestyle, but also changes in gut microbiota associated with diseases (diabetes, obesity, allergies, cancer, Parkinson, Alzheimer…).

NCT ID: NCT05530720 Completed - General Population Clinical Trials

Acceptance of Complementary Medicine in Germany

Start date: September 19, 2022
Phase:
Study type: Observational

Complementary medicine is widely practiced in Germany and worldwide. The aim of this study is to explore how many people use complementary medicine methods in Germany, for which health-related issues they do and for which they would not.

NCT ID: NCT05403398 Completed - General Population Clinical Trials

BSCU1 and Immune Function

Start date: June 7, 2022
Phase: N/A
Study type: Interventional

The current study aims to explore a range of possible pathways by which BSCU1 could beneficially modulate the immune system, in three target populations representing the general population.

NCT ID: NCT05400824 Recruiting - Clinical trials for Cardiovascular Diseases

Metabolic and Infectious Diseases in La Réunion (the REUNION Population-based Study)

Start date: May 1, 2022
Phase:
Study type: Observational

The aim of the present study is to determine the prevalence of cardiometabolic and infectious disease in La Reunion (french oversea department and region of France). Known or suspected risk factor for these diseases will also be assessed, such as microbiota, cognitive impairement, social inequalities, and genetics.

NCT ID: NCT05338372 Completed - General Population Clinical Trials

Effects of Forest Therapy on Physical and Psychological Parameters in the General Population

Start date: May 2, 2022
Phase: N/A
Study type: Interventional

In recent years, nature and forest therapy has increasingly become the focus of medical research. Recent scientific findings indicate overall positive effects of nature and forest therapy on physical and mental health. In Asia and Australia, it has already been implemented as a public health concept of prevention and health promotion. The aim of the project is to replicate the experience gained in Asia over the last three decades on the physical and psychological effects of nature/forest therapy in the context of the German forest and to investigate it further scientifically.

NCT ID: NCT05336604 Recruiting - General Population Clinical Trials

STUDY OF THE COVID-19 EPIDEMIC AND SOCIO-ECONOMIC LIVING CONDITIONS IN FRANCE

EpiCov
Start date: May 2, 2020
Phase:
Study type: Observational

EpiCov is a population-based cohort which aims to provide national and regional estimates of seroprevalence of SARS-CoV-2 infection and analyse relations between living conditions and the dynamics of the epidemic in France. The study population is a random sample of individuals aged 15 years and older, excluding people living in residences for the elderly and living in jail. The participants are recruited from the French national tax register and is representative of the population living in France. Home self-samples on Dried Blood Spots (DBS) for IgG and neutralizing antibodies detection were offered to a random national sub-sample of 12,114 in the 1st round of the EPICOV survey (May 2020) and to all respondents in the 2nd round (November 2020), including also serological testing for all members (≥ 6 years old) of household for 20% of index participants. A third round was perfomed in June-July 2021, without serological measurements. Overall, 134,391 participants have been enrolled in first-round (May 2020). Among them, 107 759 participated to the second round (November 2020) and 85 074 in third round (June 2021). The next wave is expected in March-april 2022.

NCT ID: NCT05328856 Recruiting - General Population Clinical Trials

Effects of Vital Shower on Quality of Life, Immune Function, Cardiovascular Regulation and Well-being

Start date: May 25, 2022
Phase: N/A
Study type: Interventional

The aim of this exploratory randomized controlled clinical study is to evaluate the health-promoting effects of Kneipp hydrotherapy, in the form of the Vital Shower, a variation of the alternating warm and cold showers, in a four-week daily application. The hydrotherapy will be carried out in the home environment using a shower prototype from Hansgrohe.